{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:40:15Z","timestamp":1777585215300,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.dsx.2021.02.026","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T22:33:49Z","timestamp":1614206029000},"page":"505-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges"],"prefix":"10.1016","volume":"15","author":[{"given":"Rimesh","family":"Pal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-8778","authenticated-orcid":false,"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.02.026_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.dsx.2020.04.049","article-title":"COVID-19 and diabetes mellitus: an unholy interaction of two pandemics","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.02.026_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.dsx.2020.12.029","article-title":"High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes","volume":"15","author":"Mithal","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.02.026_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.dsx.2020.05.050","article-title":"Managing common endocrine disorders amid COVID-19 pandemic","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.02.026_bib4","doi-asserted-by":"crossref","first-page":"108132","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","volume":"162","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2021.02.026_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia \u2013 a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.02.026_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc20-2260","article-title":"COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic\u2019s impact in type 1 and type 2 diabetes","volume":"44","author":"Gregory","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.02.026_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2021.02.026_bib8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.02.026_bib9","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2337\/dc20-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: Standards of medical Care in diabetes\u20142020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.02.026_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diacare.23.1.95","article-title":"Use of influenza and pneumococcal vaccines in people with diabetes","volume":"23","author":"Smith","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.02.026_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/adc.78.1.54","article-title":"Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus","volume":"78","author":"Volti","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.dsx.2021.02.026_bib12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4103\/2230-8210.102982","article-title":"Suggested use of vaccines in diabetes","volume":"16","author":"Kesavadev","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.02.026_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.2012.194","article-title":"Prevention of pneumococcal infection with vaccines: an evolving story","volume":"307","author":"Shapiro","year":"2012","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2021.02.026_bib14","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2021.02.026_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004064","article-title":"Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly","volume":"95","author":"Kuo","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.dsx.2021.02.026_bib16","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.vaccine.2013.05.003","article-title":"Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine","volume":"31","author":"Frasca","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.dsx.2021.02.026_bib17","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc05-2517","article-title":"Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients","volume":"29","author":"Looijmans-Van den Akker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.02.026_bib18","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2021.02.026_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2021.02.026_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2021.02.026_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2021.02.026_bib22","unstructured":"Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK phase 3 trial [Internet]. [cited 2021 Aug 2]. Available from: https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3."},{"key":"10.1016\/j.dsx.2021.02.026_bib25","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","author":"Ella","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.dsx.2021.02.026_bib26","unstructured":"ChAdOx1 nCoV- 19 corona virus vaccine (recombinant) COVISHIELDTM [Internet]. [cited 2021 Aug 2]. Available from: https:\/\/www.seruminstitute.com\/product_covishield.php."},{"key":"10.1016\/j.dsx.2021.02.026_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.dsx.2020.12.035","article-title":"Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: a preliminary report","volume":"15","author":"Pal","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.02.026_bib28","article-title":"Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia","volume":"dgab055","author":"Dispinseri","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.02.026_bib29","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s00125-020-05284-4","article-title":"Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study","volume":"63","author":"Lampasona","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.02.026_bib30","unstructured":"Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID- 19 developed by Oxford University and AstraZeneca [Internet]. [cited 2021 Nov 2]. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1."},{"key":"10.1016\/j.dsx.2021.02.026_bib31","unstructured":"The advisory committee on immunization Practices\u2019 updated interim recommendation for allocation of COVID-19 vaccine \u2014 United States, december 2020 [Internet]. [cited 2021 Nov 2]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm695152e2.htm?s_cid=mm695152e2_w."},{"key":"10.1016\/j.dsx.2021.02.026_bib32","unstructured":"Coronavirus vaccines and diabetes [Internet]. [cited 2021 Aug 2]. Available from: https:\/\/www.diabetes.org.uk\/about_us\/news\/coronavirus-vaccines."}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:13:48Z","timestamp":1761729228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1871402121000564"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.02.026","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}